APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decentralized Clinical Trial Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Decentralized Clinical Trial Software Industry Growth and Trends Forecast to 2032

2 May 2026124 pages

Choose your research edition.

Industry ResearchDecentralized Clinical Trial Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Decentralized Clinical Trial Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Decentralized Clinical Trial Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decentralized Clinical Trial Software Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Decentralized Clinical Trial Software Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

According to APO Research, the global Decentralized Clinical Trial Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Decentralized Clinical Trial Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Decentralized Clinical Trial Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decentralized Clinical Trial Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Decentralized Clinical Trial Software market include Medrio, Medable, TCS, Castor EDC, THREAD, ObvioHealth, Power, Veeva and SAHMRI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Decentralized Clinical Trial Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Decentralized Clinical Trial Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Decentralized Clinical Trial Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Decentralized Clinical Trial Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Decentralized Clinical Trial Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Decentralized Clinical Trial Software Market by Company

Medrio

Medable

TCS

Castor EDC

THREAD

ObvioHealth

Power

Veeva

SAHMRI

IMI CARE

DNDi

Clario

Castor

Curebase

Infiuss

AGILE

OpenClinica

ClinCapture

DFdiscover

ClinPlus CTMS

Dacima Clinical Suite

Smartsheet

Snappii

RealTime-CTMS

Decentralized Clinical Trial Software Segment by Type

Web-based

Cloud-based

Decentralized Clinical Trial Software Segment by Application

Medical Device & Diagnostics

Biotech & Pharma

Contract Research Organizations

Academic Research

Others

Decentralized Clinical Trial Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trial Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trial Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trial Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Decentralized Clinical Trial Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Decentralized Clinical Trial Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Decentralized Clinical Trial Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Decentralized Clinical Trial Software Market Share by Region (2021-2026) Table 4. Global Decentralized Clinical Trial Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Decentralized Clinical Trial Software Market Share by Region (2027-2032) Table 6. Global Decentralized Clinical Trial Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Decentralized Clinical Trial Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Decentralized Clinical Trial Software Market Size Share by Type (2021-2026) Table 9. Global Decentralized Clinical Trial Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Decentralized Clinical Trial Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Decentralized Clinical Trial Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Decentralized Clinical Trial Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Decentralized Clinical Trial Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Decentralized Clinical Trial Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Decentralized Clinical Trial Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Decentralized Clinical Trial Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Decentralized Clinical Trial Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Decentralized Clinical Trial Software Market Size Share by Application (2021-2026) Table 24. Global Decentralized Clinical Trial Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Decentralized Clinical Trial Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Decentralized Clinical Trial Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Decentralized Clinical Trial Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Decentralized Clinical Trial Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Decentralized Clinical Trial Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Decentralized Clinical Trial Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Decentralized Clinical Trial Software Industry Trends Table 37. Decentralized Clinical Trial Software Industry Drivers Table 38. Decentralized Clinical Trial Software Industry Opportunities and Challenges Table 39. Decentralized Clinical Trial Software Industry Restraints Table 40. Global Decentralized Clinical Trial Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Decentralized Clinical Trial Software Revenue Market Share by Company (2021-2026) Table 42. Global Decentralized Clinical Trial Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Decentralized Clinical Trial Software Key Company Headquarters & Area Served Table 44. Global Decentralized Clinical Trial Software Company, Product Type & Application Table 45. Global Decentralized Clinical Trial Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Decentralized Clinical Trial Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Medrio Company Information Table 49. Medrio Business Overview Table 50. Medrio Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Medrio Decentralized Clinical Trial Software Product Portfolio Table 52. Medrio Recent Development Table 53. Medable Company Information Table 54. Medable Business Overview Table 55. Medable Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Medable Decentralized Clinical Trial Software Product Portfolio Table 57. Medable Recent Development Table 58. TCS Company Information Table 59. TCS Business Overview Table 60. TCS Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. TCS Decentralized Clinical Trial Software Product Portfolio Table 62. TCS Recent Development Table 63. Castor EDC Company Information Table 64. Castor EDC Business Overview Table 65. Castor EDC Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Castor EDC Decentralized Clinical Trial Software Product Portfolio Table 67. Castor EDC Recent Development Table 68. THREAD Company Information Table 69. THREAD Business Overview Table 70. THREAD Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. THREAD Decentralized Clinical Trial Software Product Portfolio Table 72. THREAD Recent Development Table 73. ObvioHealth Company Information Table 74. ObvioHealth Business Overview Table 75. ObvioHealth Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ObvioHealth Decentralized Clinical Trial Software Product Portfolio Table 77. ObvioHealth Recent Development Table 78. Power Company Information Table 79. Power Business Overview Table 80. Power Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Power Decentralized Clinical Trial Software Product Portfolio Table 82. Power Recent Development Table 83. Veeva Company Information Table 84. Veeva Business Overview Table 85. Veeva Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Veeva Decentralized Clinical Trial Software Product Portfolio Table 87. Veeva Recent Development Table 88. SAHMRI Company Information Table 89. SAHMRI Business Overview Table 90. SAHMRI Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SAHMRI Decentralized Clinical Trial Software Product Portfolio Table 92. SAHMRI Recent Development Table 93. IMI CARE Company Information Table 94. IMI CARE Business Overview Table 95. IMI CARE Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. IMI CARE Decentralized Clinical Trial Software Product Portfolio Table 97. IMI CARE Recent Development Table 98. DNDi Company Information Table 99. DNDi Business Overview Table 100. DNDi Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. DNDi Decentralized Clinical Trial Software Product Portfolio Table 102. DNDi Recent Development Table 103. Clario Company Information Table 104. Clario Business Overview Table 105. Clario Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Clario Decentralized Clinical Trial Software Product Portfolio Table 107. Clario Recent Development Table 108. Castor Company Information Table 109. Castor Business Overview Table 110. Castor Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Castor Decentralized Clinical Trial Software Product Portfolio Table 112. Castor Recent Development Table 113. Curebase Company Information Table 114. Curebase Business Overview Table 115. Curebase Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Curebase Decentralized Clinical Trial Software Product Portfolio Table 117. Curebase Recent Development Table 118. Infiuss Company Information Table 119. Infiuss Business Overview Table 120. Infiuss Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Infiuss Decentralized Clinical Trial Software Product Portfolio Table 122. Infiuss Recent Development Table 123. AGILE Company Information Table 124. AGILE Business Overview Table 125. AGILE Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AGILE Decentralized Clinical Trial Software Product Portfolio Table 127. AGILE Recent Development Table 128. OpenClinica Company Information Table 129. OpenClinica Business Overview Table 130. OpenClinica Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. OpenClinica Decentralized Clinical Trial Software Product Portfolio Table 132. OpenClinica Recent Development Table 133. ClinCapture Company Information Table 134. ClinCapture Business Overview Table 135. ClinCapture Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. ClinCapture Decentralized Clinical Trial Software Product Portfolio Table 137. ClinCapture Recent Development Table 138. DFdiscover Company Information Table 139. DFdiscover Business Overview Table 140. DFdiscover Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. DFdiscover Decentralized Clinical Trial Software Product Portfolio Table 142. DFdiscover Recent Development Table 143. ClinPlus CTMS Company Information Table 144. ClinPlus CTMS Business Overview Table 145. ClinPlus CTMS Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. ClinPlus CTMS Decentralized Clinical Trial Software Product Portfolio Table 147. ClinPlus CTMS Recent Development Table 148. Dacima Clinical Suite Company Information Table 149. Dacima Clinical Suite Business Overview Table 150. Dacima Clinical Suite Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Dacima Clinical Suite Decentralized Clinical Trial Software Product Portfolio Table 152. Dacima Clinical Suite Recent Development Table 153. Smartsheet Company Information Table 154. Smartsheet Business Overview Table 155. Smartsheet Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Smartsheet Decentralized Clinical Trial Software Product Portfolio Table 157. Smartsheet Recent Development Table 158. Snappii Company Information Table 159. Snappii Business Overview Table 160. Snappii Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Snappii Decentralized Clinical Trial Software Product Portfolio Table 162. Snappii Recent Development Table 163. RealTime-CTMS Company Information Table 164. RealTime-CTMS Business Overview Table 165. RealTime-CTMS Decentralized Clinical Trial Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. RealTime-CTMS Decentralized Clinical Trial Software Product Portfolio Table 167. RealTime-CTMS Recent Development Table 168. North America Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Decentralized Clinical Trial Software Market Share by Country (2021-2026) Table 171. North America Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Decentralized Clinical Trial Software Market Share Forecast by Country (2027-2032) Table 173. Europe Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Decentralized Clinical Trial Software Market Share by Country (2021-2026) Table 176. Europe Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Decentralized Clinical Trial Software Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Decentralized Clinical Trial Software Market Share by Country (2021-2026) Table 181. Asia-Pacific Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Decentralized Clinical Trial Software Market Share Forecast by Country (2027-2032) Table 183. Latin America Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Decentralized Clinical Trial Software Market Share by Country (2021-2026) Table 186. Latin America Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Decentralized Clinical Trial Software Market Share Forecast by Country (2027-2032) Table 188. Middle East & Africa Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East & Africa Decentralized Clinical Trial Software Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East & Africa Decentralized Clinical Trial Software Market Share by Country (2021-2026) Table 191. Middle East & Africa Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East & Africa Decentralized Clinical Trial Software Market Share Forecast by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Decentralized Clinical Trial Software Product Image Figure 3. Global Decentralized Clinical Trial Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Decentralized Clinical Trial Software Market Size (2021-2032) & (US$ Million) Figure 5. Global Decentralized Clinical Trial Software Market Share by Region: 2025 VS 2032 Figure 6. Global Decentralized Clinical Trial Software Market Share by Region (2021-2032) Figure 7. North America Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Web-based Image Figure 13. Global Web-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cloud-based Image Figure 15. Global Cloud-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Decentralized Clinical Trial Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Decentralized Clinical Trial Software Market Share by Type 2025 VS 2032 Figure 18. North America Decentralized Clinical Trial Software Market Size Share by Type (2021-2032) Figure 19. Europe Decentralized Clinical Trial Software Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Decentralized Clinical Trial Software Market Size Share by Type (2021-2032) Figure 21. Latin America Decentralized Clinical Trial Software Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Decentralized Clinical Trial Software Market Size Share by Type (2021-2032) Figure 23. Medical Device & Diagnostics Image Figure 24. Global Medical Device & Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Biotech & Pharma Image Figure 26. Global Biotech & Pharma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Contract Research Organizations Image Figure 28. Global Contract Research Organizations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Academic Research Image Figure 30. Global Academic Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Decentralized Clinical Trial Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Decentralized Clinical Trial Software Market Share by Application 2025 VS 2032 Figure 35. North America Decentralized Clinical Trial Software Market Size Share by Application (2021-2032) Figure 36. Europe Decentralized Clinical Trial Software Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Decentralized Clinical Trial Software Market Size Share by Application (2021-2032) Figure 38. Latin America Decentralized Clinical Trial Software Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Decentralized Clinical Trial Software Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Decentralized Clinical Trial Software Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Decentralized Clinical Trial Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Decentralized Clinical Trial Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 45. Europe Decentralized Clinical Trial Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Decentralized Clinical Trial Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 48. Asia-Pacific Decentralized Clinical Trial Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Decentralized Clinical Trial Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 51. Latin America Decentralized Clinical Trial Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Decentralized Clinical Trial Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 54. Middle East & Africa Decentralized Clinical Trial Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Decentralized Clinical Trial Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Decentralized Clinical Trial Software Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Web-based
  • Cloud-based
Applications
  • Medical Device & Diagnostics
  • Biotech & Pharma
  • Contract Research Organizations
  • Academic Research
  • Others
Companies covered
  • Medrio
  • Medable
  • TCS
  • Castor EDC
  • THREAD
  • ObvioHealth
  • Power
  • Veeva
  • SAHMRI
  • IMI CARE
  • DNDi
  • Clario
  • Castor
  • Curebase
  • Infiuss
  • AGILE
  • OpenClinica
  • ClinCapture
  • DFdiscover
  • ClinPlus CTMS
  • Dacima Clinical Suite
  • Smartsheet
  • Snappii
  • RealTime-CTMS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Decentralized Clinical Trial Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Decentralized Clinical Trial Software Market Size by Region (2021-2032)
  5. 1.4.1 Global Decentralized Clinical Trial Software Market Size by Region (2021-2026)
  6. 1.4.2 Global Decentralized Clinical Trial Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions Decentralized Clinical Trial Software Market Size (2021-2032)
  8. 1.5.1 North America Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Decentralized Clinical Trial Software Market Size Growth Rate (2021-2032)
2 Decentralized Clinical Trial Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Web-based
  3. 2.1.2 Cloud-based
  4. 2.2 Global Decentralized Clinical Trial Software Market Size by Type
  5. 2.2.1 Global Decentralized Clinical Trial Software Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Decentralized Clinical Trial Software Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Decentralized Clinical Trial Software Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Decentralized Clinical Trial Software Market Size by Regions
  9. 2.3.1 North America Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Decentralized Clinical Trial Software Market Size Breakdown by Type (2021-2026)
3 Decentralized Clinical Trial Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Device & Diagnostics
  3. 3.1.2 Biotech & Pharma
  4. 3.1.3 Contract Research Organizations
  5. 3.1.4 Academic Research
  6. 3.1.5 Others
  7. 3.2 Global Decentralized Clinical Trial Software Market Size by Application
  8. 3.2.1 Global Decentralized Clinical Trial Software Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Decentralized Clinical Trial Software Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Decentralized Clinical Trial Software Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Decentralized Clinical Trial Software Market Size by Regions
  12. 3.3.1 North America Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Decentralized Clinical Trial Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Decentralized Clinical Trial Software Industry Trends
  2. 4.2 Decentralized Clinical Trial Software Industry Drivers
  3. 4.3 Decentralized Clinical Trial Software Industry Opportunities and Challenges
  4. 4.4 Decentralized Clinical Trial Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Decentralized Clinical Trial Software Revenue (2021-2026)
  2. 5.2 Global Decentralized Clinical Trial Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Decentralized Clinical Trial Software Key Company Headquarters & Area Served
  4. 5.4 Global Decentralized Clinical Trial Software Company, Product Type & Application
  5. 5.5 Global Decentralized Clinical Trial Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Decentralized Clinical Trial Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Decentralized Clinical Trial Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Decentralized Clinical Trial Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Medrio
  2. 6.1.1 Medrio Company Information
  3. 6.1.2 Medrio Business Overview
  4. 6.1.3 Medrio Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Medrio Decentralized Clinical Trial Software Product Portfolio
  6. 6.1.5 Medrio Recent Developments
  7. 6.2 Medable
  8. 6.2.1 Medable Company Information
  9. 6.2.2 Medable Business Overview
  10. 6.2.3 Medable Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Medable Decentralized Clinical Trial Software Product Portfolio
  12. 6.2.5 Medable Recent Developments
  13. 6.3 TCS
  14. 6.3.1 TCS Company Information
  15. 6.3.2 TCS Business Overview
  16. 6.3.3 TCS Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 TCS Decentralized Clinical Trial Software Product Portfolio
  18. 6.3.5 TCS Recent Developments
  19. 6.4 Castor EDC
  20. 6.4.1 Castor EDC Company Information
  21. 6.4.2 Castor EDC Business Overview
  22. 6.4.3 Castor EDC Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Castor EDC Decentralized Clinical Trial Software Product Portfolio
  24. 6.4.5 Castor EDC Recent Developments
  25. 6.5 THREAD
  26. 6.5.1 THREAD Company Information
  27. 6.5.2 THREAD Business Overview
  28. 6.5.3 THREAD Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 THREAD Decentralized Clinical Trial Software Product Portfolio
  30. 6.5.5 THREAD Recent Developments
  31. 6.6 ObvioHealth
  32. 6.6.1 ObvioHealth Company Information
  33. 6.6.2 ObvioHealth Business Overview
  34. 6.6.3 ObvioHealth Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ObvioHealth Decentralized Clinical Trial Software Product Portfolio
  36. 6.6.5 ObvioHealth Recent Developments
  37. 6.7 Power
  38. 6.7.1 Power Company Information
  39. 6.7.2 Power Business Overview
  40. 6.7.3 Power Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Power Decentralized Clinical Trial Software Product Portfolio
  42. 6.7.5 Power Recent Developments
  43. 6.8 Veeva
  44. 6.8.1 Veeva Company Information
  45. 6.8.2 Veeva Business Overview
  46. 6.8.3 Veeva Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Veeva Decentralized Clinical Trial Software Product Portfolio
  48. 6.8.5 Veeva Recent Developments
  49. 6.9 SAHMRI
  50. 6.9.1 SAHMRI Company Information
  51. 6.9.2 SAHMRI Business Overview
  52. 6.9.3 SAHMRI Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SAHMRI Decentralized Clinical Trial Software Product Portfolio
  54. 6.9.5 SAHMRI Recent Developments
  55. 6.10 IMI CARE
  56. 6.10.1 IMI CARE Company Information
  57. 6.10.2 IMI CARE Business Overview
  58. 6.10.3 IMI CARE Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 IMI CARE Decentralized Clinical Trial Software Product Portfolio
  60. 6.10.5 IMI CARE Recent Developments
  61. 6.11 DNDi
  62. 6.11.1 DNDi Company Information
  63. 6.11.2 DNDi Business Overview
  64. 6.11.3 DNDi Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 DNDi Decentralized Clinical Trial Software Product Portfolio
  66. 6.11.5 DNDi Recent Developments
  67. 6.12 Clario
  68. 6.12.1 Clario Company Information
  69. 6.12.2 Clario Business Overview
  70. 6.12.3 Clario Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Clario Decentralized Clinical Trial Software Product Portfolio
  72. 6.12.5 Clario Recent Developments
  73. 6.13 Castor
  74. 6.13.1 Castor Company Information
  75. 6.13.2 Castor Business Overview
  76. 6.13.3 Castor Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Castor Decentralized Clinical Trial Software Product Portfolio
  78. 6.13.5 Castor Recent Developments
  79. 6.14 Curebase
  80. 6.14.1 Curebase Company Information
  81. 6.14.2 Curebase Business Overview
  82. 6.14.3 Curebase Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Curebase Decentralized Clinical Trial Software Product Portfolio
  84. 6.14.5 Curebase Recent Developments
  85. 6.15 Infiuss
  86. 6.15.1 Infiuss Company Information
  87. 6.15.2 Infiuss Business Overview
  88. 6.15.3 Infiuss Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Infiuss Decentralized Clinical Trial Software Product Portfolio
  90. 6.15.5 Infiuss Recent Developments
  91. 6.16 AGILE
  92. 6.16.1 AGILE Company Information
  93. 6.16.2 AGILE Business Overview
  94. 6.16.3 AGILE Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AGILE Decentralized Clinical Trial Software Product Portfolio
  96. 6.16.5 AGILE Recent Developments
  97. 6.17 OpenClinica
  98. 6.17.1 OpenClinica Company Information
  99. 6.17.2 OpenClinica Business Overview
  100. 6.17.3 OpenClinica Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 OpenClinica Decentralized Clinical Trial Software Product Portfolio
  102. 6.17.5 OpenClinica Recent Developments
  103. 6.18 ClinCapture
  104. 6.18.1 ClinCapture Company Information
  105. 6.18.2 ClinCapture Business Overview
  106. 6.18.3 ClinCapture Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 ClinCapture Decentralized Clinical Trial Software Product Portfolio
  108. 6.18.5 ClinCapture Recent Developments
  109. 6.19 DFdiscover
  110. 6.19.1 DFdiscover Company Information
  111. 6.19.2 DFdiscover Business Overview
  112. 6.19.3 DFdiscover Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 DFdiscover Decentralized Clinical Trial Software Product Portfolio
  114. 6.19.5 DFdiscover Recent Developments
  115. 6.20 ClinPlus CTMS
  116. 6.20.1 ClinPlus CTMS Company Information
  117. 6.20.2 ClinPlus CTMS Business Overview
  118. 6.20.3 ClinPlus CTMS Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 ClinPlus CTMS Decentralized Clinical Trial Software Product Portfolio
  120. 6.20.5 ClinPlus CTMS Recent Developments
  121. 6.21 Dacima Clinical Suite
  122. 6.21.1 Dacima Clinical Suite Company Information
  123. 6.21.2 Dacima Clinical Suite Business Overview
  124. 6.21.3 Dacima Clinical Suite Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Dacima Clinical Suite Decentralized Clinical Trial Software Product Portfolio
  126. 6.21.5 Dacima Clinical Suite Recent Developments
  127. 6.22 Smartsheet
  128. 6.22.1 Smartsheet Company Information
  129. 6.22.2 Smartsheet Business Overview
  130. 6.22.3 Smartsheet Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Smartsheet Decentralized Clinical Trial Software Product Portfolio
  132. 6.22.5 Smartsheet Recent Developments
  133. 6.23 Snappii
  134. 6.23.1 Snappii Company Information
  135. 6.23.2 Snappii Business Overview
  136. 6.23.3 Snappii Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Snappii Decentralized Clinical Trial Software Product Portfolio
  138. 6.23.5 Snappii Recent Developments
  139. 6.24 RealTime-CTMS
  140. 6.24.1 RealTime-CTMS Company Information
  141. 6.24.2 RealTime-CTMS Business Overview
  142. 6.24.3 RealTime-CTMS Decentralized Clinical Trial Software Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 RealTime-CTMS Decentralized Clinical Trial Software Product Portfolio
  144. 6.24.5 RealTime-CTMS Recent Developments
7 North America
  1. 7.1 North America Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  3. 7.3 North America Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  3. 8.3 Europe Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  3. 10.3 South America Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Decentralized Clinical Trial Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Decentralized Clinical Trial Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Decentralized Clinical Trial Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst